Investigation on pancreatic cancer showed that some Bcl-XL (an anti-apoptotic factor of the Bcl-2 family) sequence-specific antisense oligonucleotides could suppress pancreatic tumor growth and sensitize tumor cells to gemcitabine [49]. Here, BCL2 is linked to neoplasm.